Thursday, May 4  | 15:00 – 15:20 pm

Why Longevity Clinicians need a powerful data analysis tool to provide evidence-based, effective longevity support

By James Raaf, Biokineticist and Member of the Healthy Longevity Medicine Society and leads the clinical team at Biolytica AG

Harnessing the skills of longevity physicians, clinicians, bioinformaticians, AI, data development specialists and myriad longevity professionals, we believe that the enormously complex challenge of addressing human aging requires both holistic and integrative perspectives, as well as a novel reductionist approach to deep analytics.

Thursday, May 4  | 15:40 – 16:00 pm

Artificial Intelligence (AI) in Longevity Medicine Restoring to Biological Age of an individual performance

by Evelyne Bischof, MD, MPF, FEFIM, University Hospital Renji of Jiatong University, Shangai, PRC

Longevity medicine is AI—driven precision medicine aiming at expanding the healthy lifespan by identifying the risks of diseases, mitigating and eliminating them. Longevity industry has been named one of the next trillion-dollar industry. China is one of the absolute global leaders in longevity and healthy aging, Recent advances in deep learning enabled the development of AI systems that outperform humans in many tasks and have started to empower scientists and physicians with new tools. In this talk, Prof. Dr. med. Evelyne Yehudit Bischof, discusses what is applied longevity medicine, how she leads her longevity patients in China and worldwide, and which and how exponentially growing applications of AI are emerging in the field of longevity.

Friday, May 5  | 9:20 – 9:40 am

Quantum Healthy Longevity: Connecting Healthy People and Healthy for Health Growth

by Tina Woods, Founder of Collider Health, London, UK

In her role as Healthy Longevity Champion working with the National Innovation Centre for Ageing (NICA) in the UK, Tina Woods sets out the vision for a ‘Healthy Longevity Innovation Mission’ to harness science, technology, investment and policy for global sustainable impact. This Innovation Mission aims to ensure better health, ageing and wellbeing in the UK and globally, The blueprint for the Innovation Mission is geared to develop UK’s global leadership in science and technology, and support the ambition to aggregate and accelerate a national federated, open, data-driven, knowledge and insight epicentre harnessing ethically-driven AI to scale societal and commercial impact and meet UK’s government’s goal to increase healthy life expectancy and close the gap in health and wellbeing inequalities.

Thursday, May 5  | 11:50 – 12:10 am

Big data and the science of ageing

by João Pedro Magalhães, Principal Investigator, Genomics of Ageing and Rejuvenation Lab, Birmingham, UK

Age-related conditions are the leading causes of death and healthcare costs. Retarding the ageing process would have enormous medical and financial benefits. A large number of genes and drugs extending lifespan in model organisms already exist, yet given long validation times, only a small fraction of them can be explored for humans clinical applications. Therefore, prioritizing drugs and gene targets is imperative. In this talk, I will present big data and machine learning approaches for predicting longevity genes and compounds, which we validated experimentally. I will also present integrative, multi-dimensional approaches that provide insights into longevity pathways and their role in age-related diseases. Overall, our data-driven approaches allow us to identify and prioritize further compounds with potential healthy longevity properties.